17.60
-1.68%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Lukas Biomedical
Its shares trade on Taipei Exchange under the ticker 6814.TWO. It has been listed since 31 December 2020. In the fiscal year to 31 December 2025, it reported revenue of TWD 179.5m and a net loss of TWD 85.6m. At that date it held total assets of TWD 426.8m and shareholders' equity of TWD 240.2m.
Lukas Biomedical, Inc. engages in the lease and sale of medical equipment. The company is headquartered in Taipei, New Taipei. The company went IPO on 2020-12-31. The firm is also engaged in the research, design, development and manufacture of immune cell products. The Company’s products are involved in beauty cosmetics, skin care products, daily necessities including dental floss, chewing gum, chewing spray, dry hair and other products. The firm also provides makeup series products including contains eye shadow gel, eye color palette, lip gloss, lipstick, lip wax. The medical equipment, care institutions and medical management’s products and services are engaged in the development of the experience charging model of entity operations with the service model of brand authorization, management consulting, property leasing and medical equipment leasing.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 31 Dec 2020
- Website
- lukas-bio.com.tw ↗
Leadership
Pay as last reported
- Mr. Zhichao TangChairman of the Board, since 2017
- Chao'an LiuGeneral Manager, Director, since 2021
- Ms. Dailin LiuDeputy General Manager, Director, since 2018
- Wenxuan ChengHead of Accounting
- Bingzhong LiuChief Medical Officer
- Ms. Eleanore NewHead of Finance, Corporate Governance Officer
- Mr. Jiqing FuIndependent Director
- Nanguang ShiIndependent Director
- Mr. Zhongping WangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Lukas Biomedical Inc. focuses on immune cell products and medical equipment leasing in Taipei, Taiwan.
- The company develops beauty cosmetics and skin care products for daily use in the Health Care sector.
- Lukas Biomedical Inc. offers makeup series including eye shadow gel and lip gloss under its brand.
Weaknesses
- Lukas Biomedical Inc. relies on medical equipment leasing and sales for revenue in Taipei, Taiwan.
- The firm's product range includes dental floss and chewing gum, which may not align with core Health Care focus.
- Lukas Biomedical Inc. operates in a competitive Health Care market with limited product diversification.
Opportunities
- Lukas Biomedical Inc. can expand immune cell product development in the Health Care sector.
- The company may leverage brand authorization and management consulting services in medical equipment leasing.
- Lukas Biomedical Inc. can grow its makeup series products in the Consumer Discretionary segment.
Threats
- Lukas Biomedical Inc. faces competition from established medical equipment providers in Taiwan.
- The firm's reliance on dental floss and chewing gum products may attract regulatory scrutiny in Health Care.
- Lukas Biomedical Inc. must navigate regulatory challenges in the Immobilien sector for medical management services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.